Coronavirus particle assembly: Primary structure requirements of the membrane protein

Journal of Virology

Volumn 72, Issue 8, 1998, Pages 6838-6850

  De Haan, Cornelis A M ^a   Kuo, Lili ^b   Masters, Paul S ^b   Vennema, Harry ^a   Rottier, Peter J M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN BHK; CONCENTRATION RESPONSE; GLYCOSYLATION; MURINE HEPATITIS CORONAVIRUS; MUTATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS; VIRUS ASSEMBLY; VIRUS GENOME; VIRUS PARTICLE;

EID: 0031950008     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.8.6838-6850.1998     Document Type: Article

References (79)

1. Allison, S. L., K. Stadler, C. W. Mandl, C. Kunz, and F. X. Heinz. 1995. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J. Virol. 69:5816-5820.
2. Armstrong, J., H. Niemann, S. Smeekens, P. Rottier, and G. Warren. 1984. Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirus. Nature 308:751-752.
3. Arpin, N., and P. J. Talbot. 1990. Molecular characterization of the 229E strain of human coronavirus. Adv. Exp. Med. Biol. 276:73-80.
4. Barth, B. U., M. Suomalainen, P. Liljeström, and H. Garoff. 1992. Alphavirus assembly and entry: role of the cytoplasmic tail of the E1 spike subunit. J. Virol. 66:7560-7564.
5. Bilsel, P., M. R. Castrucci, and Y. Kawaoka. 1993. Mutations in the cytoplasmic tail of influenza A virus neuraminidase affect incorporation into virions. J. Virol. 67:6762-6767.
6. Bos, E. C., W. Luytjes, H. V. van der Meulen, H. K. Koerten, and W. J. M. Spaan. 1996. The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus. Virology 218:52-60.
7. Brian, D. A., B. G. Hogue, and T. E. Kienzle. 1995. The coronavirus hemagglutinin esterase glycoprotein, p. 165-179. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
8. Cosson, P. 1996. Direct interaction between the envelope and matrix protein of HIV-1. EMBO J. 15:5783-5788.
9. Delchambre, M., D. Gheysen, D. Thines, C. Thiriart, E. Jacobs, E. Verdin, M. Horth, A. Burny, and F. Bex. 1989. The Gag precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J. 8:2653-2660.
10. S) of equine arteritis virus folds into three distinct monomers and a disulfide-linked dimer. J. Virol. 69:3441-3448.
11. Dubay, J. W., S. J. Roberts, B. H. Hahn, and E. Hunter. 1992. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 66:6616-6625.
12. Duffus, W. A., P. Levy-Mintz, M. R. Klimjack, and M. Kielian. 1995. Mutations in the putative fusion peptide of Semliki Forest virus affect spike protein oligomerization and virus assembly. J. Virol. 69:2471-2479.
13. Ekström, M., P. Liljeström, and H. Garoff. 1994. Membrane protein lateral interactions control Semliki Forest virus budding. EMBO J. 13:1058-1064.
14. Elbein, D. A. 1987. Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Annu. Rev. Biochem. 56:497-534.
15. Elroy-Stein, O., and B. Moss. 1990. Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells. Proc. Natl. Acad. Sci. USA 87:6743-6747.
16. Fischer, F., C. F. Stegen, C. A. Koetzner, and P. S. Masters. 1997. Analysis of a recombinant mouse hepatitis virus expressing a foreign gene reveals a novel aspect of coronavirus transcription. J. Virol. 71:5148-5160.
17. Fleming, J. O., R. A. Shubin, M. A. Sussman, N. Casteel, and S. A. Stohlman. 1989. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 168:162-167.
18. Freed, E. O., and M. A. Martin. 1996. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70:341-351.
19. Freed, E. O., and M. A. Martin. 1995. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69:1984-1989.
20. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
21. Fuhrmann, U., E. Bause, G. Legler, and H. Ploegh. 1984. Novel mannosidase inhibitor blocking conversion of high mannose to complex oligosaccharides. Nature 307:755-758.
22. Gavel, Y., and G. von Heijne. 1990. Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering. Protein Eng. 3:433-442.
23. Gheysen, D., E. Jacobs, A. de Foresta, C. Thiriart, M. Francotte, D. Thines, and M. De Wilde. 1989. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected cells. Cell 59:103-112.
24. Gray, K. D., and M. J. Roth. 1993. Mutational analysis of the envelope gene of Moloney murine leukemia virus. J. Virol. 67:3489-3496.
25. Hahn, C. S., C. M. Rice, E. G. Strauss, E. M. Lenches, and J. H. Strauss. 1989. Sindbis virus ts103 has a mutation in glycoprotein E2 that leads to defective assembly of virions. J. Virol. 63:3459-3465.
26. Hobman, T. C., M. L. Lundstrom, C. A. Mauracher, L. Woodward, S. Gilliam, and M. G. Farquhar. 1994. Assembly of rubella virus structural proteins into virus-like particles in transfected cells. Virology 202:574-585.
27. Holmes, K. V., E. W. Doller, and L. S. Sturman. 1981. Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein. Virology 115:334-344.
28. Homberger, F. R. 1994. Nucleotide sequence comparison of the membrane protein genes of three enterotropic strains of mouse hepatitis virus. Virus Res. 31:49-56.
29. Ivanova, L., and M. J. Schlesinger. 1993. Site-directed mutations in the Sindbis virus E2 glycoprotein identify palmitoylation sites and affect virus budding. J. Virol. 67:2546-2551.
30. Jin, H., G. P. Leser, and R. A. Lamb. 1994. The influenza virus hemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity. EMBO J. 13:5504-5515.
31. Karacostas, V., K. Nagashima, M. A. Gonda, and B. Moss. 1989. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc. Natl. Acad. Sci. USA 86:8964-8967.
32. King, B., and D. A. Brian. 1982. Bovine coronavirus structural proteins. J. Virol. 42:700-707.
33. Klumperman, J., J. Krijnse Locker, A. Meijer, M. C. Horzinek, H. J. Geuze, and P. J. M. Rottier. 1994. Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding. J. Virol. 68:6523-6534.
34. Krijnse Locker, J., G. Griffiths, M. C. Horzinek, and P. J. M. Rottier. 1992. O-glycosylation of the coronavirus M protein. Differential localization of sialyltransferases in N- and O-glycosylation. J. Biol. Chem. 267:14094-14101.
35. Krijnse Locker, J., M. Ericsson, P. J. M. Rottier, and G. Griffiths. 1994. Characterization of the budding compartment of mouse hepatitis virus: evidence that transport from the RER to the Golgi complex requires only one vesicular transport step. J. Cell Biol. 124:55-70.
36. Krijnse Locker, J., D.-J. E. Opstelten, M. Ericsson, M. C. Horzinek, and P. J. M. Rottier. 1995. Oligomerization of a trans-Golgi/trans-Golgi network retained protein occurs in the Golgi complex and may be part of its retention. J. Biol. Chem. 270:8815-8821.
37. Krijnse Locker, J., J. K. Rose, M. C. Horzinek, and P. J. M. Rottier. 1992. Membrane assembly of the triple-spanning coronavirus M protein; individual transmembrane domains show preferred orientation. J. Biol. Chem. 267: 21911-21918.
38. Laemmli, U. K. 1970. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680-685.
39. Lanser, J. A., and C. R. Howard. 1980. The polypeptides of infectious bronchitis virus (IBV-41 strain). J. Gen. Virol. 46:349-361.
40. Laude, H., J. Gelfi, L. Lavenant, and B. Charley. 1992. Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus. J. Virol. 66:743-749.
41. Lindqvist, B. H., J. DiSalvo, C. M. Rice, J. H. Strauss, and E. G. Strauss. 1986. Sindbis virus mutant ts20 of complementation group E contains a lesion in glycoprotein E2. Virology 151:10-20.
42. Lopez, S., J.-S. Yao, R. J. Kuhn, E. G. Strauss, and J. H. Strauss. 1994. Nucleocapsid-glycoprotein interactions required for assembly of alphaviruses. J. Virol. 68:1316-1323.
43. Mammano, F., E. Kondo, J. Sodroski, A. Bukovsky, and H. G. Göttlinger. 1995. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 69:3824-3830.
44. Mason, P. W., S. Pincus, M. J. Fournier, T. L. Mason, R. E. Shope, and E. Paoletti. 1991. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 180:294-305.
45. Masters, P. S., C. A. Koetzner, C. A. Kerr, and Y. Heo. 1994. Optimization of targeted RNA recombination and mapping of a novel nucleocapsid gene mutation in the coronavirus mouse hepatitis virus. J. Virol. 68:328-337.
46. Mayer, T., T. Tamura, M. Falk, and H. Niemann. 1988. Membrane integration and intracellular transport of the coronavirus glycoprotein E1, a class III membrane glycoprotein. J. Biol. Chem. 263:14956-14963.
47. Mead, D. A., E. Szczesna-Skorupa, and B. Kemper. 1986. Single-stranded DNA 'blue' T7 promoter plasmids: a versatile tandem promoter system for cloning and protein engineering. Protein Eng. 1:67-74.
48. Mebatsion, T., M. König, and K.-K. Conzelman. 1996. Budding of rabies virus particles in the absence of the spike glycoprotein. Cell 84:941-951.
49. Mitnaul, L. J., M. R. Castrucci, K. G. Murti, and Y. Kawaoka. 1996. The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication. J. Virol. 70:873-879.
50. Moremen, K. W., O. Touster, and P. W. Robbins. 1991. Novel purification of the catalytic domain of a Golgi α-mannosidase II: characterization and comparison with the intact enzyme. J. Biol. Chem. 266:16876-16885.
51. Mounir, S., and P. J. Talbot. 1992. Sequence analysis of the membrane protein gene of human coronavirus OC43 and evidence for O-glycosylation. J. Gen. Virol. 73:2731-2736.
52. Naim, H. Y., and M. G. Roth. 1993. Basis for selective incorporation of glycoproteins into the influenza virus envelope. J. Virol. 67:4831-4841.
53. Niemann, H., B. Boschek, D. Evans, M. Rosing, T. Tamura, and H. D. Klenk. 1982. Post-translational glycosylation of coronavirus glycoprotein E1: inhibition by monensin. EMBO J. 1:1499-1504.
54. Niemann, H., G. Heisterberg-Moutsis, R. Geyer, H.-D. Klenk, and M. Wirth. 1984. Glycoprotein E1 of MHV-A59: structure of the O-linked carbohydrates and construction of full length cDNA clones. Adv. Exp. Med. Biol. 173:201-213.
55. Opstelten, D. J., M. J. Raamsman, K. Wolfs, M. C. Horzinek, and P. J. M. Rottier. 1995. Envelope glycoprotein interactions in coronavirus assembly. J. Cell Biol. 131:339-349.
56. Owen, K. E., and R. J. Kuhn. 1997. Alphavirus budding is dependent on the interaction between the nucleocapsid and hydrophobic amino acids on the cytoplasmic domain of the E2 envelope glycoprotein. Virology 230:187-196.
57. Owens, R. J., and J. K. Rose. 1993. Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus. J. Virol. 67:360-365.
58. Patzer, E. J., G. R. Nakamura, C. C. Simonsen, A. D. Levinson, and R. Brands. 1986. Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum. J. Virol. 58:884-892.
59. Peng, D., C. A. Koetzner, T. McMahon, Y. Zhu, and P. S. Masters. 1995. Construction of murine coronavirus mutants containing interspecies chimeric nucleocapsid proteins. J. Virol. 69:5475-5484.
60. Peng, D., and P. S. Masters. Unpublished data.
61. Rottier, P., J. Armstrong, and D. I. Meyer. 1985. Signal recognition particle-dependent insertion of coronavirus E1, an intracellular membrane glycoprotein. J. Biol. Chem. 260:4648-4652.
62. Rottier, P. J. M. 1995. The coronavirus membrane protein, p. 115-139. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
63. Rottier, P. J. M., M. C. Horzinek, and B. A. M. van der Zeijst. 1981. Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin. J. Virol. 40:350-357.
64. Rottier, P. J. M., J. Krijnse Locker, M. C. Horzinek, and W. J. M. Spaan. 1990. Expression of MHV-A59 M glycoprotein: effects of deletions on membrane integration and intracellular transport. Adv. Exp. Med. Biol. 276:127-135.
65. Rottier, P. J. M., and J. K. Rose. 1987. Coronavirus E1 glycoprotein expressed from cloned cDNA localizes in the Golgi region. J. Virol. 61:2042-2045.
66. Siddell, S. G. 1995. The small-membrane protein, p. 181-189. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
67. Simon, K., V. R. Lingappa, and D. Ganem. 1988. Secreted hepatitis B surface antigen polypeptides are derived from a transmembrane precursor. J. Cell Biol. 107:2163-2168.
68. Simpson, D. A., and R. A. Lamb. 1992. Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity. J. Virol. 66:790-803.
69. Stern, D. F., and B. M. Sefton. 1982. Coronavirus proteins: structure and function of the oligosaccharides of the avian infectious bronchitis virus glycoproteins. J. Virol. 44:804-812.
70. Sturman, L. S., K. V. Holmes, and J. Behnke. 1980. Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J. Virol. 33:449-462.
71. Suomalainen, M., P. Liljeström, and H. Garoff. 1992. Spike protein-nucleocapsid interactions drive the budding of alphaviruses. J. Virol. 66:4737-4747.
72. Tooze, S. A., J. Tooze, and G. Warren. 1988. Site of addition of N-acetyl-galactosamine to the E1 glycoprotein of mouse hepatitis virus-A59. J. Cell Biol. 106:1475-1487.
73. Vennema, H., G.-J. Godeke, J. W. A. Rossen, W. F. Voorhout, M. C. Horzinek, D.-J. E. Opstelten, and P. J. M. Rottier. 1996. Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J. 15:2020-2028.
74. Vennema, H., R. Rijnbrand, L. Heijnen, M. C. Horzinek, and W. J. Spaan. 1991. Enhancement of the vaccinia virus/phage T7 RNA polymerase expression system using encephalomyocarditis virus 5′-untranslated region sequences. Gene 108:201-209.
75. Wege, H., H. Wege, K. Nagashima, and V. ter Meulen. 1979. Structural polypeptides of the murine coronavirus JHM. J. Gen. Virol. 42:37-47.
76. Whitt, M. A., L. Chong, and J. K. Rose. 1989. Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant. J. Virol. 63:3569-3578.
77. Yu, X., X. Yuan, M. F. McLane, T.-H. Lee, and M. Essex. 1993. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J. Virol. 67:213-221.
78. Zhao, H., B. Lindqvist, H. Garoff, C.-H. von Bonsdorff, and P. Liljeström. 1994. A tyrosine-based motif in the cytoplasmic domain of the alphavirus envelope protein is essential for budding. EMBO J. 13:4204-4211.
79. Zoller, M. J., and M. Smith. 1982. Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA. Nucleic Acids Res. 10:6487-6500.